First, we analyzed the expression profile of ten transcript variants of tpd52l2 in different cancer types from 33 cohorts of TCGA dataset via hierarchical clustering and verified two predominantly expressed transcript variants, V5 and V6, in breast cancer and several other cancer types (Figure 4(a)). This evidence concerns the gene TPD52L2 and breast cancer.